Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Milligan

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Thrombosis Research|July 27, 2005
Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplementsBrian F Gage, Paul E Milligan
Biomedical Instrumentation & Technology|May 18, 2018
Case Study: Continuous Bedside Capnography Monitoring of High-Risk Patients Receiving OpioidsPaul E Milligan, Yao Zhang, Sally Graver
Current Hematology Reports|August 7, 2003
Risk factors for bleeding in patients taking coumarinsRebecca J Beyth, Paul E Milligan, Brian F Gage
The American Journal of Medicine|December 25, 2003
Perioperative reduction of the warfarin dosePaul E Milligan, Gerald A Banet, Brian F Gage
The Annals of Pharmacotherapy|April 30, 2002
Substitution of generic warfarin for Coumadin in an HMO settingPaul E Milligan, Gerald A Banet, Amy D Waterman, et al.
Chest|February 11, 2003
Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratioGerald A Banet, Amy D Waterman, Paul E Milligan, et al.
Thrombosis and Haemostasis|December 24, 2003
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinBrian F Gage, Charles Eby, Paul E Milligan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 21, 2004
Effect of warfarin nonadherence on control of the International Normalized RatioAmy D Waterman, Paul E Milligan, Laura Bayer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare systemPaul E Milligan, Mary C Bocox, Elizabeth Pratt, et al.
Thrombosis Research|December 5, 2013
Risk factors for inpatient venous thromboembolism despite thromboprophylaxisTzu-Fei Wang, Catherine A Wong, Paul E Milligan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Thrombosis Research|July 27, 2005
Pharmacology and pharmacogenetics of warfarin and other coumarins when used with supplementsBrian F Gage, Paul E Milligan
Biomedical Instrumentation & Technology|May 18, 2018
Case Study: Continuous Bedside Capnography Monitoring of High-Risk Patients Receiving OpioidsPaul E Milligan, Yao Zhang, Sally Graver
Current Hematology Reports|August 7, 2003
Risk factors for bleeding in patients taking coumarinsRebecca J Beyth, Paul E Milligan, Brian F Gage
The American Journal of Medicine|December 25, 2003
Perioperative reduction of the warfarin dosePaul E Milligan, Gerald A Banet, Brian F Gage
The Annals of Pharmacotherapy|April 30, 2002
Substitution of generic warfarin for Coumadin in an HMO settingPaul E Milligan, Gerald A Banet, Amy D Waterman, et al.
Chest|February 11, 2003
Warfarin dose reduction vs watchful waiting for mild elevations in the international normalized ratioGerald A Banet, Amy D Waterman, Paul E Milligan, et al.
Thrombosis and Haemostasis|December 24, 2003
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarinBrian F Gage, Charles Eby, Paul E Milligan, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 21, 2004
Effect of warfarin nonadherence on control of the International Normalized RatioAmy D Waterman, Paul E Milligan, Laura Bayer, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 20, 2015
Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare systemPaul E Milligan, Mary C Bocox, Elizabeth Pratt, et al.
Thrombosis Research|December 5, 2013
Risk factors for inpatient venous thromboembolism despite thromboprophylaxisTzu-Fei Wang, Catherine A Wong, Paul E Milligan, et al.
Pageof 2